RxDoctor Payments Data

Adrienne Terry

Physician Assistant · Lehi, UTNPI 1134648520

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (41.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Lilly USA, LLC accounts for 65.9% of it on its own, with 42 other manufacturers making up the rest. Reporting peaked in 2024 at $11,678 and has fallen 91.4% since, to $1,006 in 2025. Among physician assistant clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,429in general payments, 2019–2025

Across 423 payments — averaging $38.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$11K
  • Xeris Pharmaceuticals, Inc.$652
  • Novo Nordisk$555
  • Amgen$475
  • Boehringer Ingelheim$403
  • AstraZeneca$311
  • plus $3K from 37 others

What the payments were for

  • Consulting fees$4503%
  • Speaking & faculty fees$6,63840%
  • Travel & lodging$2,44915%
  • Food & beverage$6,88242%
  • Education$120%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$16,429 in reported general payments places this provider in the 95th percentile of 1,543 physician assistant providers in Utah.

See all physician assistant providers in Utah

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide111$154,147
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog69$142,258
MounjaroTirzepatide98$110,341
Humalog Kwikpen U-200Insulin Lispro22$81,326
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog51$68,588
TrulicityDulaglutide43$56,518
JardianceEmpagliflozin57$54,227
Tresiba Flextouch U-200Insulin Degludec43$53,055
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/739$46,796
Soliqua 100-33Insulin Glargine/Lixisenatide28$32,777
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt32$32,301
TymlosAbaloparatide12$31,108
Tresiba Flextouch U-100Insulin Degludec25$25,106
Fiasp FlextouchInsulin Aspart (Niacinamide)14$24,616
FarxigaDapagliflozin Propanediol27$23,034

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro$10,829$180,736188 claims
Novo NordiskOzempic$555$154,147111 claims
Boehringer IngelheimJardiance, Synjardy Xr, Trijardy Xr$403$86,92984 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$192$32,77728 claims
Radius Health, Inc.Tymlos$65$31,10812 claims
AstraZenecaFarxiga$311$23,03427 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$14$1,235154 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,543 physician assistant providers in Utah.

Other physician assistant in Lehi

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →